3D Bioprinting - Global Strategic Business Report

The global market for 3D Bioprinting is estimated at US$2.9 Billion in 2023 and is projected to reach US$7.9 Billion by 2030, growing at a CAGR of 15.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Inkjet-based Technology segment, which is expected to reach US$3.3 Billion by 2030 with a CAGR of a 16.2%. The Magnetic Levitation Technology segment is also set to grow at 16.8% CAGR over the next 7 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $881.3 Million in 2023, and China, forecasted to grow at an impressive 14.8% CAGR to reach $1.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global 3D Bioprinting Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global 3D Bioprinting Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global 3D Bioprinting Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as 3D Bioprinting Solutions, 3D Systems, Advanced Solutions Life Sciences, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 34 Featured):

3D Bioprinting Solutions
3D Systems
Advanced Solutions Life Sciences
Allevi Inc.
Aspect Biosystems Ltd.
Bio3D Technologies
Cellink
Cellink Global
Cyfuse Biomedical K.K.
Digilab, Inc.
Envisiontec
Gesim
Inventia Life Science Pty Ltd.
Materialise NV
Nano3D Biosciences, Inc.
Oceanz 3D printing & Additive Manufacturing
Organovo Holdings, Inc.
Poietis
Regemat 3D S.L.
Regenhu
Regenovo Biotechnology Co., Ltd.
Rokit Healthcare
Solidscape
Stratasys Ltd.
Tevido Biodevices
Vivax Bio, LLC
Voxeljet

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Global Economic Update
3D Bioprinting - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Living Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World 7-Year Perspective for Living Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 4: World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Extracellular Matrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World 7-Year Perspective for Extracellular Matrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World 7-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 9: World Recent Past, Current & Future Analysis for Research Organizations & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 10: World 7-Year Perspective for Research Organizations & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 12: World 7-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 15: World 3D Bioprinting Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 16: World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World 7-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
Table 18: World Recent Past, Current & Future Analysis for Inkjet-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 19: World 7-Year Perspective for Inkjet-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 20: World Recent Past, Current & Future Analysis for Magnetic Levitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 21: World 7-Year Perspective for Magnetic Levitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Laser-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World 7-Year Perspective for Laser-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 24: World Recent Past, Current & Future Analysis for Other Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 25: World 7-Year Perspective for Other Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 26: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: USA 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 28: USA Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 29: USA 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 30: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 31: USA 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

CANADA

Table 32: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Canada 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 34: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 35: Canada 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 36: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 37: Canada 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

JAPAN

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 38: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: Japan 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 40: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 41: Japan 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 42: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 43: Japan 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

CHINA

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 44: China Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: China 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 46: China Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 47: China 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 48: China Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 49: China 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

EUROPE

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 50: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: Europe 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 52: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 53: Europe 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 54: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 55: Europe 7-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 57: Europe 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

FRANCE

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 58: France Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 59: France 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 60: France Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 61: France 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 62: France Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 63: France 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

GERMANY

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 64: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 65: Germany 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 66: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 67: Germany 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 68: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 69: Germany 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

ITALY

Table 70: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 71: Italy 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 72: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 73: Italy 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 74: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 75: Italy 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

UNITED KINGDOM

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 76: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 77: UK 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 78: UK Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 79: UK 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 80: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 81: UK 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

REST OF EUROPE

Table 82: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 83: Rest of Europe 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 84: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 85: Rest of Europe 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 87: Rest of Europe 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

ASIA-PACIFIC

3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 88: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 89: Asia-Pacific 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 91: Asia-Pacific 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 93: Asia-Pacific 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

REST OF WORLD

Table 94: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 95: Rest of World 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2024 & 2030
Table 96: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 97: Rest of World 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2024 & 2030
Table 98: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 99: Rest of World 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2024 & 2030

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

3D Bioprinting Solutions
3D Systems
Advanced Solutions Life Sciences
Allevi Inc.
Aspect Biosystems Ltd.
Bio3D Technologies
Cellink
Cellink Global
Cyfuse Biomedical K.K.
Digilab, Inc.
Envisiontec
Gesim
Inventia Life Science Pty Ltd.
Materialise NV
Nano3D Biosciences, Inc.
Oceanz 3D printing & Additive Manufacturing
Organovo Holdings, Inc.
Poietis
Regemat 3D S.L.
Regenhu
Regenovo Biotechnology Co., Ltd.
Rokit Healthcare
Solidscape
Stratasys Ltd.
Tevido Biodevices
Vivax Bio, LLC
Voxeljet

Table Information

Report Attribute	Details
No. of Pages	89
Published	October 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 2.9 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.9 Billion
Compound Annual Growth Rate	15.5%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5329EUR$5,600USD£4,494GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10124EUR$10,640USD£8,538GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15986EUR$16,800USD£13,482GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 34 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

3D Bioprinting Market Report by Component, Application, End User, and Region 2024-2032

3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Forecast to 2029

3D Bioprinting Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Component, Type of Consumable, Type of Technology, Type of Material Used, Application Area, End User, Geographical Regions and Key Players

3D Bioprinting Global Market Report 2024

3D Bioprinting - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)